Certain Prostate Drugs Tied to Risk for Parkinson Disease
Use of glycolysis - enhancing drugs terazosin, doxazosin, or alfuzosin tied to lower risk for developing Parkinson disease than use of tamsulosin (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 18, 2021 Category: Cancer & Oncology Tags: Neurology, Oncology, Pharmacy, Urology, Journal, Source Type: news
Certain Prostate Drugs Tied to Risk for Parkinson Disease
THURSDAY, Feb. 18, 2021 -- Users of terazosin, doxazosin, or alfuzosin are at lower risk for developing Parkinson disease (PD) compared with users of tamsulosin, according to a study published online Feb. 1 in JAMA Neurology.
Jacob E. Simmering,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 18, 2021 Category: Pharmaceuticals Source Type: news
Prostate Drugs Tied to Lower Risk for Parkinson's Prostate Drugs Tied to Lower Risk for Parkinson's
Men taking terazosin, doxazosin, or alfuzosin for benign prostatic hyperplasia, drugs that enhance glycolysis, had lower risk of incident PD vs tamsulosin, a similar drug that does not affect glycolysis.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - February 9, 2021 Category: Drugs & Pharmacology Tags: Neurology & Neurosurgery News Source Type: news
Prostate drug associated with lower risk of Parkinson's disease
(University of Iowa Health Care) Taking a particular type of medication to treat enlarged prostate is associated with a reduced risk of developing Parkinson's disease, according to a large observational study by researchers at the University of Iowa, and colleagues in Denmark and China. The findings, published in JAMA Neurology, suggest that terazosin, and similar medications, might have potential to prevent or delay the development of Parkinson's disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 1, 2021 Category: International Medicine & Public Health Source Type: news
Drug that treats an enlarged prostate may 'slow disability' in Parkinson's sufferers
A team of international scientists, including researchers from Capital Medical University in Beijing, tested the drug terazosin in 13 men with Parkinson's disease. (Source: the Mail online | Health)
Source: the Mail online | Health - September 16, 2019 Category: Consumer Health News Source Type: news
terazosin (Hytrin)
Title: terazosin (Hytrin)Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 3/20/2019 12:00:00 AM (Source: MedicineNet Mens Health General)
Source: MedicineNet Mens Health General - March 20, 2019 Category: Primary Care Source Type: news
Terazosin Hydrochloride Capsules (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - June 5, 2018 Category: Drugs & Pharmacology Source Type: news
Hytrin (Terazosin Hcl) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 18, 2017 Category: Drugs & Pharmacology Source Type: news
terazosin, Hytrin
Title: terazosin, HytrinCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 11/4/2016 12:00:00 AM (Source: MedicineNet Mens Health General)
Source: MedicineNet Mens Health General - November 4, 2016 Category: Primary Care Source Type: news
